ArticleInternational journal of rheumatic diseases2026
Case Report: Anifrolumab for Refractory Cutaneous Lupus Erythematosus: Relapse After Treatment Interruption and Response to Rechallenge.
Yuanzun Peng et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.